Glenn Flux - Concepedia

Author

Glenn Flux

Royal Marsden NHS Foundation Trust ORCID

Also Known As

Flux, GD, Flux, Glenn, Flux, Glenn, D., G D Flux, G Flux, G. D. Flux, G. Flux, G.D. Flux, Glen Flux, Glenn D Flux

215

Publications

Citations

H-Index

Concepts

All Affiliations

Royal Marsden NHS Foundation Trust Institute of Cancer Research Royal Marsden Hospital Lund University Hospital de Cruces

About

Glenn Flux is an author at Royal Marsden NHS Foundation Trust specializing in medicine, radiology, and nuclear medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	30	2.1K
2	Health Sciences	19	28	1.6K
3	Engineering	8	8	290
4	Biostatistics	3	3	61
5	Biomedical Engineering	2	2	51

Glenn Flux

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry Cécilia Hindorf, Gerhard Glatting, Ola Lindén, European Journal of Nuclear Medicine and Molecular Imaging Bone Marrow FailureHematologyBlood DonationBone MarrowDosimetry	2010	283
EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy Heribert Hänscheid, Cécilia Hindorf, Glenn Flux, European Journal of Nuclear Medicine and Molecular Imaging OncologyRadiation TherapyThyroid DiseaseStandard Operational ProceduresBone Marrow Dosimetry	2008	240
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds Francesco Giammarile, Lisa Bodei, Glenn Flux, European Journal of Nuclear Medicine and Molecular Imaging Eanm Procedure GuidelineHepatologyRadiation TherapyMedicineHepatobiliary Tumor	2011	226
EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations Jonathan Gear, M G Cox, Johan Gustafsson, European Journal of Nuclear Medicine and Molecular Imaging	2018	208
EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting Claudio Chiesa, Glenn Flux, Manuel Bardiès European Journal of Nuclear Medicine and Molecular Imaging Radiation TestingGood PracticePatient SafetyClinical GuidanceClinical Dosimetry Reporting	2010	186
Feasibility of Dosimetry-Based High-Dose <sup>131</sup> I-Meta-Iodobenzylguanidine with Topotecan as a Radiosensitizer in Children with Metastatic Neuroblastoma Mark N. Gaze, Yen-Ching Chang, Glenn Flux, Cancer Biotherapy and Radiopharmaceuticals	2005	141
EANM Dosimetry Committee Series on Standard Operational Procedures for Pre-Therapeutic Dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseases Heribert Hänscheid, Cristina Canzi, W. Eschner, European Journal of Nuclear Medicine and Molecular Imaging Nuclear MedicinePre-therapeutic Dosimetry IiThyroid DiseaseBenign Thyroid DiseasesRadiation Dose	2013	135
EANM dosimetry committee series on standard operational procedures: a unified methodology for 99mTc-MAA pre- and 90Y peri-therapy dosimetry in liver radioembolization with 90Y microspheres Katarina Sjögreen Gleisner, Stéphan Walrand, Lidia Strigari, EJNMMI Physics	2021	119
A bone marrow toxicity model for<sup>223</sup>Ra alpha-emitter radiopharmaceutical therapy Robert F. Hobbs, Hong Song, C Watchman, Physics in Medicine and Biology EngineeringRadiation ExposureTreatment VerificationRadiation TestingRadiation Medicine	2012	118
FDG–PET in the prediction of survival of patients with cancer of the pancreas: a pilot study N. Maisey, Andrew Webb, Glenn Flux, British Journal of Cancer Oncologic ImagingPrognosisPathologyResponse AssessmentPilot Study	2000	116

Page 1